Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
26.77
-0.38 (-1.40%)
At close: Dec 5, 2025, 4:00 PM EST
26.00
-0.77 (-2.88%)
After-hours: Dec 5, 2025, 6:34 PM EST
Amphastar Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 professional analysts, the 12-month price target for Amphastar Pharmaceuticals stock ranges from a low of $25 to a high of $35. The average analyst price target of $31.2 forecasts a 16.55% increase in the stock price over the next year.
Price Target: $31.20 (+16.55%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Amphastar Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 6 | 6 | 6 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Maintains $36 → $34 | Strong Buy | Maintains | $36 → $34 | +27.01% | Nov 7, 2025 |
| Needham | Needham | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +34.48% | Oct 22, 2025 |
| B of A Securities | B of A Securities | Hold Maintains $28 → $32 | Hold | Maintains | $28 → $32 | +19.54% | Aug 26, 2025 |
| Needham | Needham | Hold → Strong Buy Upgrades $36 | Hold → Strong Buy | Upgrades | $36 | +34.48% | Aug 12, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $30 → $25 | Hold | Maintains | $30 → $25 | -6.61% | Aug 8, 2025 |
Financial Forecast
Revenue This Year
741.87M
from 731.97M
Increased by 1.35%
Revenue Next Year
779.71M
from 741.87M
Increased by 5.10%
EPS This Year
3.53
from 3.06
Increased by 15.21%
EPS Next Year
3.76
from 3.53
Increased by 6.65%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 768.8M | 840.7M | ||||
| Avg | 741.9M | 779.7M | ||||
| Low | 702.2M | 712.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 5.0% | 13.3% | ||||
| Avg | 1.4% | 5.1% | ||||
| Low | -4.1% | -4.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 3.72 | 4.34 | ||||
| Avg | 3.53 | 3.76 | ||||
| Low | 3.25 | 3.27 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 21.5% | 23.2% | ||||
| Avg | 15.2% | 6.7% | ||||
| Low | 6.4% | -7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.